Your browser doesn't support javascript.
loading
[Obesity, insulin resistance and type 2 diabetes: risk factors for breast cancer]. / Obésité, insulinorésistance et diabète de type 2: facteurs de risque du cancer du sein.
Scheen, A J; Beck, E; De Flines, J; Rorive, M.
Affiliation
  • Scheen AJ; Université de Liège, Belgique.
Rev Med Liege ; 66(5-6): 238-44, 2011.
Article de Fr | MEDLINE | ID: mdl-21826954
ABSTRACT
Obesity and type 2 diabetes are two risk factors of breast cancer, especially after menopause. Underlying mechanisms are multiple and include hyperinsulinism due to insulin resistance (insulin, as insulin-like-growth factor -IGF-, is a growth factor), hyperleptinaemia associated with hypoadiponectinaemia, and high levels of estrogens resulting from aromatization of androgens in adipose tissue. In presence of type 2 diabetes associated with obesity, hyperglycaemia might provide energy substrate promoting tumour growth. These data have therapeutic implications with expected favourable effects of weight loss, resulting in a reduction of fat mass and insulin resistance, and the promising results recently reported with metformin contrasting with the negative effects of exogenous administration of high doses of insulin.
Sujet(s)
Recherche sur Google
Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du sein / Insulinorésistance / Diabète de type 2 / Obésité Type d'étude: Etiology_studies / Risk_factors_studies Limites: Female / Humans Langue: Fr Journal: Rev Med Liege Année: 2011 Type de document: Article Pays d'affiliation: Belgique
Recherche sur Google
Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du sein / Insulinorésistance / Diabète de type 2 / Obésité Type d'étude: Etiology_studies / Risk_factors_studies Limites: Female / Humans Langue: Fr Journal: Rev Med Liege Année: 2011 Type de document: Article Pays d'affiliation: Belgique